钾离子通道蛋白家族KCNQ2抗体

Quantity size:

0.2ml

Concentration:

1mg/ml 钾离子通道蛋白家族KCNQ2抗体  Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

Epilepsy affects about 0.5% of the world’s population and has a large genetic component. Epilepsy results from an electrical hyperexcitability in the central nervous system. Potassium channels are important regulators of electrical signaling, determining the firing properties and responsiveness of a variety of neurons. Benign familial neonatal钾离子通道蛋白家族KCNQ2抗体 convulsions (BFNC), an autosomal dominant epilepsy of infancy, has been shown to be caused by mutations in the KCNQ2 or the KCNQ3 potassium channel genes. KCNQ2 and KCNQ3 are voltage-gated potassium channel proteins with six putative transmembrane domains. Both proteins display a broad distribution within the brain, with expression patterns that largely overlap.

钾离子通道蛋白家族KCNQ2抗体Also known as:

BFNC; BFNS1; EBN 1; EBN; EBN1; EIEE7; ENB 1; ENB1; HNSPC; KCNA 11; KCNA11; KCNQ 2; Kcnq2; KCNQ2_HUMAN; KQT like 2; KQT-like 2; KV7.2; KVEBN 1; KVEBN1; KvLQT 2; KvLQT2; Neuroblastoma specific potassium channel alpha subunit KvLQT2; Neuroblastoma specific potassium channel protein; Neuroblastoma specific potassium channel subunit alpha; Neuroblastoma specific potassium channel subunit alpha KvLQT2; Neuroblastoma-specific钾离子通道蛋白家族KCNQ2抗体 potassium channel subunit alpha KvLQT2; Potassium voltage gated channel KQT like protein 2; Potassium voltage gated channel KQT like subfamily member 2; Potassium voltage gated

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Dog, Cow, Horse, Sheep, .

●

Immunogen: KLH conjugated synthetic peptide derived from human KCNQ2 (9.

●

钾离子通道蛋白家族KCNQ2抗体Predicted Molecular Weight: 96kDa.

Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  Flow-Cyt=1:20-200  ICC=1:100-500  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl449Ra01胱天蛋白酶7(CASP7)多克隆抗体Polyclonal Antibody to Caskle 7 (CASP7)

kl450Hu01激肽释放酶4(KLK4)多克隆抗体Polyclonal Antibody to Kallikrein 4 (KLK4)

kl450Mu01激肽释放酶4(KLK4)多克隆抗体Polyclonal Antibody to Kallikrein 4 (KLK4)

kl450Ra01激肽释放酶4(KLK4)多克隆抗体Polyclonal Antibody to Kallikrein 4 (KLK4)

kl451Hu01激肽释放酶5(KLK5)多克隆抗体Polyclonal Antibody to Kallikrein 5 (KLK5)

kl451Mu01激肽释放酶5(KLK5)多克隆抗体Polyclonal Antibody to Kallikrein 5 (KLK5)

kl457Hu01胱天蛋白酶14(CASP14)多克隆抗体Polyclonal Antibody to Caskle 14 (CASP14)

kl457Mu01胱天蛋白酶14(CASP14)多克隆抗体Polyclonal Antibody to Caskle 14 (CASP14)

kl457Ra01胱天蛋白酶14(CASP14)多克隆抗体Polyclonal Antibody to Caskle 14 (CASP14)

kl464Hu01盐皮质激素受体(MR)多克隆抗体Polyclonal Antibody to Mineralocorticoid Receptor (MR)

kl464Ra01盐皮质激素受体(MR)多克隆抗体Polyclonal Antibody to Mineralocorticoid Receptor (MR)

kl468Hu01衰变加速因子(DAF)多克隆抗体Polyclonal Antibody to Decay Accelerating Factor (DAF)

kl470Hu01热休克转录因子2(HSF2)多克隆抗体Polyclonal Antibody to Heat Shock Transcription Factor 2 (HSF2)

kl471Bo01骨钙素(OC)多克隆抗体Polyclonal Antibody to Osteocalcin (OC)

kl471Ca01骨钙素(OC)多克隆抗体Polyclonal Antibody to Osteocalcin (OC)

kl471Hu01骨钙素(OC)多克隆抗体Polyclonal Antibody to Osteocalcin (OC)

kl471Mu01骨钙素(OC)多克隆抗体Polyclonal Antibody to Osteocalcin (OC)

kl471Po01骨钙素(OC)多克隆抗体Polyclonal Antibody to Osteocalcin (OC)

kl471Ra01骨钙素(OC)多克隆抗体Polyclonal Antibody to Osteocalcin (OC)

kl471Rb51骨钙素(OC)多克隆抗体Polyclonal Antibody to Osteocalcin (OC)

kl472Ca01降钙素(CT)多克隆抗体Polyclonal Antibody to Calcitonin (CT)

kl472Hu01降钙素(CT)多克隆抗体Polyclonal Antibody to Calcitonin (CT)

kl472Mu01降钙素(CT)多克隆抗体Polyclonal Antibody to Calcitonin (CT)

kl472Ra01降钙素(CT)多克隆抗体Polyclonal Antibody to Calcitonin (CT)